Pantothen veterinary-grade API is calcium D-pantothenate (CAS 137-08-6, relative molecular mass 476.53) supplied as a white to off-white crystalline powder or spray-dried granular material with a D-pantothenic acid equivalence of 92.0% w/w. The API conforms to the USP Calcium Pantothenate monograph and Ph. Eur. monograph 0470 with assay limits of 98.0–102.0% on the dried basis, calcium content 8.2–8.6%, specific rotation [α]D20 = +25.0° to +27.5° in a 50 mg/mL aqueous solution, loss on drying not more than 5.0%, and pH of a 5% solution between 6.8 and 8.0. The compendial assay is HPLC-based and the residual solvent profile is controlled according to ICH Q3C and VICH GL18. These physical and chemical specifications fix the process windows for the downstream routes described below, because the molecule is susceptible to acid- and base-catalysed hydrolysis and to oxidation in the presence of free mineral ions.

What Limits Calcium D-Pantothenate Solubility in Cold-Chain Injectable B-Complex Formulations?

Terminal-sterilized and aseptic-filtered B-complex injections for cattle, horses, and swine use calcium D-pantothenate as the pantothenic acid source where final concentration is constrained by osmolality and pH-dependent hydrolysis of the peptide bond. At pH below 4.0 and above 8.0, hydrolysis to β-alanine and pantolactone accelerates; formulators therefore buffer the bulk solution with citrate or phosphate to 6.2–6.8 before the API is added under low-light conditions. Compliance anchors are EU Regulation 2019/6 for veterinary medicinal products, EudraLex Volume 4 GMP Annex 1 for sterile manufacture, Ph. Eur. 2.6.1 sterility, Ph. Eur. 2.6.14 bacterial endotoxins with a limit below 0.25 EU/mL for multidose parenterals, and the USP Calcium Pantothenate monograph for API identity. Addition ratios in concentrated B-complex injectables are commonly 5–25 mg/mL calcium D-pantothenate; a 100 mL vial carries 0.5–2.5 g active, equivalent to 0.46–2.3 g D-pantothenic acid. Downstream processing begins in a jacketed 500 L stainless-steel vessel with top-mounted agitator, where Water for Injections at 25–35°C is sparged with nitrogen to maintain dissolved oxygen below 0.5 mg/L; the API is dissolved first, followed by thiamine hydrochloride, riboflavin 5'-phosphate sodium, nicotinamide, and pyridoxine hydrochloride in sequence to prevent local pH incompatibility. Foaming at the liquid surface is a batch-to-batch variance indicator when the API is not pre-dissolved as a 20% stock solution; plants therefore pre-blend the powder in WFI at 30°C for 10–15 minutes before addition to the main vessel. The solution is filtered through a 0.45 µm polyethersulfone prefilter, then a 0.22 µm sterilizing-grade PVDF or PES membrane under aseptic conditions; terminal sterilisation at 121°C for 15 minutes is used only when the B-complex formulation excludes heat-labile vitamins and the manufacturer has verified pH-dependent first-order degradation kinetics under Annex 1 process validation. Cold-chain distribution at 2–8°C is applied to formulations containing riboflavin 5'-phosphate and no antioxidant, because light-induced riboflavin degradation raises pH and indirectly destabilises pantothenate. Terminal finished products include 50 mL single-dose vials for foals and calves, 100 mL, 250 mL, and 500 mL multidose amber Type II glass vials, and 10 mL companion-animal injectable vials.

Drinking-water administration in poultry and swine mandates a water-soluble powder form in which the limiting process variable is not thermal degradation but hygroscopicity and caking when the API is co-packed with citric acid, sodium bicarbonate, or electrolyte salts. Compliance is governed by EU Regulation 1831/2003 for feed additives, the FAMI-QS Code of Practice for specialty feed ingredients, GMP+ BA2, and national drinking-water registration dossiers requiring assay of pantothenic acid after storage at 40°C/75% RH for 6 months. Because no harmonised VICH drinking-water monograph fixes pantothenate inclusion, the following addition ratios are manufacturer-derived from feed intake equivalents: broilers 5–15 mg/L D-pantothenic acid, nursery swine 10–25 mg/L, and calves 20–50 mg/L during stress periods; with a 1:100 proportioner, this corresponds to a stock solution of 1–2 kg/100 L calcium D-pantothenate, using the 92% acid equivalence. Downstream manufacture uses a low-shear ribbon blender filled to 60–70% of rated capacity; the API is pre-sifted through an 800 µm stainless-steel mesh and blended with dextrose monohydrate before electrolytes are introduced, because direct API–citric acid contact at ambient humidity above 55% RH can form a slowly dissolving hydrate film. Terminal finished products include 100 g, 500 g, and 1 kg laminated foil sachets, 5 kg pails, and 10 kg bulk boxes for automatic proportioner dosing.

Calcium D-Pantothenate Stability Boundaries in Mineralized Feed Premix Lines

Trace-mineral premixes containing copper, zinc, iron, and manganese exert catalytic oxidation on unprotected vitamin B5 when free moisture from choline chloride or ambient humidity exceeds 55% RH. The API is therefore selected as the spray-dried, non-hygroscopic calcium D-pantothenate grade; its moisture sorption isotherm remains below 2.0% mass gain at 60% RH for 24 hours, and the crystalline form has a lower surface area than magnesium or sodium salts, as indicated by the same sorption measurement. Compliance anchors for this route are EU Regulation 1831/2003 Annex I category “nutritional additives – vitamins and provitamins,” GMP+ BA2, FAMI-QS, ISO 22000:2018, and Codex CXC 1-1969 HACCP guidance; batch release includes a choline chloride compatibility test and HPLC potency assay with combined vitamin B-group quantification. No maximum residue limit is fixed for pantothenic acid in EU feed law; the addition ratios are nutritional targets. Those ratios start from complete-feed pantothenic acid targets: swine diets 10–13 mg/kg, broilers 10–15 mg/kg, layers 5–10 mg/kg, and calves 15–20 mg/kg; expressed as calcium D-pantothenate at 92% equivalence, the corresponding API ranges are 10.9–14.1 mg/kg, 10.9–16.3 mg/kg, 5.4–10.9 mg/kg, and 16.3–21.7 mg/kg final feed. In a 1% vitamin premix included at 10 kg/t, this becomes an API addition of 0.54–2.17 kg/t across the four species; a 5% premix uses one-fifth of those values because the dilution factor is 50 kg/t. Downstream processing begins with stepwise dilution in a paddle mixer at 12 rpm for 8–12 minutes, followed by screening through a hammer mill with 1.0 mm mesh before the API enters the main ribbon blender. Conditioning in the pellet mill at 70–80°C for 15–30 seconds is the upper stability boundary; process validation retains potency above 97% when conditioned mash moisture is below 17% and die temperature does not exceed 82°C. If higher die temperatures are required for steam-flaked cereal rations, the vitamin is moved to post-pelleting liquid application through a spray nozzle at 0.5–1.0 bar to bypass thermal loss. Terminal finished products include 25 kg multiwall paper bags of 0.5%, 1%, and 5% vitamin premix, 1,000 kg FIBCs, and pelleted complete feed labelled in mg/kg pantothenic acid.

Compaction behaviour, not chemical stability, limits the use of Pantothen API in direct-compression canine and feline B-complex tablets. The crystalline powder has a Carr index and Hausner ratio that permit flow from a shoe-type hopper only when moisture content is below 5.0%; above this, interparticle liquid bridges produce weight variation outside USP 905 uniformity of dosage units limits. Compliance standards include FDA 21 CFR Part 507 Current Good Manufacturing Practice for Animal Food, AAFCO Official Publication dog and cat nutrient profiles, USP 905 uniformity of dosage units, and Ph. Eur. 2.9.5 uniformity of single-dose preparations. Addition ratios target 25–100 mg calcium D-pantothenate per tablet or capsule, corresponding to 23–92 mg D-pantothenic acid; a representative 500 mg adult dog chewable tablet contains 50 mg API, 300 mg microcrystalline cellulose, 120 mg dicalcium phosphate, 20 mg croscarmellose sodium, 5 mg magnesium stearate, and 5 mg silicon dioxide. Downstream tableting uses a rotary press at 8–18 kN compression force and 7–12 kp tablet hardness; capsules are filled on a dosator-type machine at 60,000 capsules/h into size #3 or #1 HPMC capsules. The main production failure is edge lamination when the API fraction above 250 µm exceeds 15%; manufacturers sieve the API through a 600 µm screen and condition the granulation at 35–45% RH to reduce electrostatic charging. Terminal finished products include 50 mg, 100 mg, and 150 mg chewable tablets, 25 mg and 50 mg capsules, and soft chews in which the API is dispersed in a lipid matrix.

When milk replacer powders are manufactured for calves and lambs, the API is not introduced before the spray dryer; it is blended into the dried powder after the oil-coating step to avoid thermal loss and to keep the pantothenate on the particle surface for rapid reconstitution. Compliance anchors are EU Regulation 1831/2003, FDA 21 CFR 582.5212 for calcium pantothenate in animal feed, and Codex CAC/RCP 54-2004 Good Animal Feeding; microbiological control follows the same environmental monitoring plan used for dry powder processing, with Enterobacteriaceae risk zones segregated. Addition ratios are set to deliver 20–50 mg calcium D-pantothenate per litre of reconstituted milk replacer, equivalent to 100–250 mg/kg powder at a dilution rate of 200 g/L. Downstream blending uses a post-drying ribbon or cone screw mixer with a maximum shear tip speed below 1.5 m/s; the API is pre-blended with skim milk powder at 1:10 for 5 minutes before addition to the main mixer. The primary process failure is segregation during pneumatic conveying to bagging hoppers because the API particle density differs from spray-dried skim milk; a milled grade with D50 between 75–150 µm and dilute-phase conveying at 18–22 m/s for short vertical runs reduce fines migration. Terminal finished products include 20 kg and 25 kg multiwall bags for calf and lamb milk replacer, 10 kg buckets, and 250 g single-dose foil pouches for orphan lambs.

When High-Dose Pantothenate Is Required in Ruminant Oral Drenches

Oral drench solutions for stressed ruminants are formulated with high-concentration calcium D-pantothenate where the primary stability risk is acid-catalysed hydrolysis if the drench base contains propionic acid or phosphoric acid as preservatives. The API is dissolved in purified water at 30–35°C before buffering to pH 6.0–7.0; sodium citrate or disodium phosphate is used instead of acetate buffers to avoid pH drift during storage. Compliance standards are EU Regulation 2019/6, Ph. Eur. 0520 oral liquids, and VICH GL18/ICH Q3C residual solvent limits for the USP-grade API. Addition ratios in a 1 L drench bottle are commonly 50–100 g/L calcium D-pantothenate for cattle and 25–50 g/L for sheep; a 10 mL dose therefore delivers 500–1,000 mg or 250–500 mg calcium D-pantothenate respectively. Downstream production uses a stainless-steel mixing vessel with diaphragm valve transfer and an in-line 0.45 µm filter; dissolved oxygen is reduced to below 0.5 mg/L by nitrogen sparging before filling into amber PET bottles. The known incompatibility is with sulfonamide-containing drench mixtures, where the pantothenate solution can reduce sulfonamide solubility; such combinations are either separated or adjusted with propylene glycol at 10–20% v/v. Terminal finished products include 1 L, 2.5 L, and 5 L HDPE or PET oral drench containers with graduated dosing chambers, 250 mL oral dosing bottles for sheep, and 10 mL single-dose syringes for neonatal calves.